Tyers Asset Management’s aTyr Pharma ATYR Stock Holding History

Tyers Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$18K	Sell	5,136 -15	-0.3%	-$55	﹤0.01%	959
2019 Q2	$26K	Hold	5,151	–	–	﹤0.01%	951
2019 Q1	$40K	Hold	5,151	–	–	﹤0.01%	932
2018 Q4	$36K	Hold	5,151	–	–	﹤0.01%	900
2018 Q3	$59K	Hold	5,151	–	–	﹤0.01%	928
2018 Q2	$66K	Hold	5,151	–	–	﹤0.01%	903
2018 Q1	$191K	Hold	5,151	–	–	0.01%	695
2017 Q4	$252K	Hold	5,151	–	–	0.01%	626
2017 Q3	$364K	Hold	5,151	–	–	0.01%	478
2017 Q2	$249K	Hold	5,151	–	–	0.01%	554
2017 Q1	$252K	Sell	5,151 -890	-15%	-$40.7K	0.01%	502
2016 Q4	$182K	Buy	+6,041	New	+$248K	0.01%	513

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GHCM

Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

MCIM

Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return

Tyers Asset Management's ATYR Position: Q3 2019 in Review

Tyers Asset Management reduced its aTyr Pharma (ATYR) stake by 0.29% in Q3 2019, selling an estimated $55 and leaving 5,136 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Tyers Asset Management first reported a position in ATYR in Q4 2016 and has held it in 12 quarters since. The position peaked at $364K in Q3 2017. 19 funds tracked by Wall St. Rank hold ATYR as of Q3 2019.

Tyers Asset Management held 5,136 shares of aTyr Pharma worth $18K as of Q3 2019.
Tyers Asset Management sold 15 aTyr Pharma shares in Q3 2019, an estimated $55.
aTyr Pharma made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #959 holding.
Tyers Asset Management first reported a position in aTyr Pharma in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's aTyr Pharma position peaked at $364K in Q3 2017.
19 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.